Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients
This study investigated whether ARNi and SGLT2i 1) improve the rate of clinical and echocardiographic CRT response and 2) have different impact based on the ischemic or non-ischemic etiology.
Source: International Journal of Cardiology - Category: Cardiology Authors: Celeste Fonderico, Valerio Pergola, Daniele Faccenda, Alfonsomaria Salucci, Gianluigi Comparone, Aldo Marrese, Giuseppe Ammirati, Luigi Cocchiara, Alfonso Varriale, Giovanni Esposito, Antonio Rapacciuolo, Teresa Strisciuglio Source Type: research
More News: Cardiac Resynchronization Therapy | Cardiology | Diovan | Heart | Heart Failure | Sodium | Study